Europe Artificial Intelligence (AI) in Healthcare Market (2025-2030)
The Europe Artificial Intelligence (AI) in Healthcare Market was valued at $21.63 Million in 2025 and projected to reach to $110.61 Million by 2030, representing a compound annual growth rate of 38.6%. Europe's AI in healthcare market is poised for exceptional growth through 2030, driven by digital health priorities, regulatory clarity, and substantial healthcare modernization investments.
Europe Artificial Intelligence (AI) in Healthcare Market Trends and Insights
- This growth trajectory reflects Europe's strong commitment to digital health innovation, regulatory frameworks supporting AI adoption, and substantial investment in healthcare infrastructure modernization.
- Europe is positioning itself as a leader in responsible AI deployment within clinical settings, driven by stringent data protection standards and collaborative research initiatives across member states. The European market benefits from advanced healthcare systems, high digital literacy, and significant government funding for AI research and development.
- Europe's emphasis on ethical AI governance and interoperability standards creates a unique competitive advantage in the global healthcare AI landscape.
- Between 2025 and 2030, Europe is expected to see accelerated adoption of AI-powered diagnostic tools, predictive analytics, and personalized medicine solutions across hospitals, clinics, and research institutions..
Key Market Statistics
- CAGR (2025-2030) 38.6% CAGR
- Market Size, 2025 ~USD 21.63 Million
- Forecast, 2030 ~USD 110.61 Million
- Geography Europe
Europe Artificial Intelligence (AI) in Healthcare Market Overview
Rapid Market Expansion :
Europe's AI in healthcare market is valued at $21.63 billion in 2025 and is projected to reach $110.61 billion by 2030, representing a robust 38.6% CAGR. This exceptional growth reflects the region's accelerating digital health transformation and increasing adoption of AI-powered clinical solutions.
Regulatory Leadership :
Europe's comprehensive regulatory frameworks, including the EU AI Act and GDPR compliance requirements, create a structured environment for responsible AI deployment in healthcare. These regulations foster trust and enable sustainable market growth while ensuring patient data protection and ethical AI practices.
Healthcare Infrastructure Investment :
European nations are significantly investing in modernizing healthcare infrastructure with AI integration. Government initiatives and public-private partnerships are driving adoption of AI diagnostics, predictive analytics, and personalized medicine across hospitals, clinics, and research institutions.
Innovation Hub Status :
Europe hosts leading AI research centers, biotech companies, and healthcare technology innovators. Strong academic institutions and venture capital support position the region as a global innovation hub for AI-driven healthcare solutions, attracting international talent and investment.
Europe Artificial Intelligence (AI) in Healthcare Market Dynamics
- The region's commitment to ethical AI development and data privacy standards creates competitive advantages while building stakeholder confidence.
- Major European economies including Germany, France, and the UK are leading adoption across diagnostic imaging, drug discovery, and clinical decision support systems. The market will be shaped by increasing interoperability standards, cross-border healthcare data sharing initiatives, and growing demand for AI solutions addressing aging populations.
- European healthcare providers are increasingly deploying AI to optimize operations, reduce costs, and improve patient outcomes.
- Continued government funding, favorable reimbursement policies, and strong intellectual property protections will sustain the region's market momentum and position Europe as a global leader in responsible AI healthcare innovation..
Related Ecosystem
Diagnostic Imaging
- Magnetic Resonance Imaging (MRI)
- Computed Tomography (CT)
- CT Scanners
- Nuclear Imaging
- Positron Emission Tomography
- Siemens healthineers
- PHILIPS HEALTHCARE
- CANON INC.
- FUJIFILM Holdings Corporation
- UNITED IMAGING HEALTHCARE CO., LTD.
Healthcare Analytics
- Machine Learning
- Natural Language Processing (NLP)
- Blood Pressure Monitors
- Computed Tomography (CT)
- Magnetic Resonance Imaging (MRI)
- Oracle Corporation
- PHILIPS HEALTHCARE
- Siemens healthineers
- Zensar Technologies Limited
- EPIC SYSTEMS CORPORATION
Healthcare It
- Computed Tomography (CT)
- Machine Learning
- Magnetic Resonance Imaging (MRI)
- Natural Language Processing (NLP)
- Predictive Analytics
- CERNER CORPORATION
- PHILIPS HEALTHCARE
- Oracle Corporation
- GE HealthCare Technologies Inc.
- Siemens healthineers
Key Takeaways
- Europe's AI in healthcare market will grow from $21.63B (2025) to $110.61B (2030), representing a 38.6% CAGR.
- Europe leads in ethical AI governance and regulatory compliance, differentiating its market from other regions.
- Strong government funding and collaborative research initiatives across Europe accelerate AI adoption in clinical settings.
- Europe's advanced healthcare infrastructure and digital literacy enable rapid deployment of AI-powered diagnostic and predictive solutions.
Artificial Intelligence (AI) in Healthcare Market Report Scope
| Report Metric | Details |
|---|---|
| Base Year | 2025 |
| Forecast Period | 2025–2039 |
| Growth Rate | CAGR of 38.6% from 2025 to 2039 |
| Market Size Base Year (Billions) | ~USD 21.63 (2025) |
| Revenue Forecast (Billions) | ~USD 110.61 (2039) |
| Segments Covered | Offering, Function, Type, Technology, Application, Modality, Deployment Model, Tool, End User |
Europe Artificial Intelligence (AI) in Healthcare Market Report Segmentation
9 segment dimensions are covered across the global market.
By Offering
- AI Technologies
- Integrated Solutions
- Niche/Point Solutions
- Services
By Function
- Administrative
- Data Management & Analytics
- Diagnosis & Early Detection
- Patient Engagement & Remote Monitoring
- Pharmacy Management
- Post-Treatment Surveillance & Survivorship Care
- Treatment Planning & Personalization
By Type
- Ambulatory Care Centers
- Asset Management
- Auto Coding
- Behavioral Therapy & Psychotherapy
- Billing & Claims Management
- Classification & Categorization
- Compliance & Documentation
- Convolutional Neural Networks (Cnn)
- Customer Relationship Management
- Cybersecurity
- Deep Learning
- Device Context
- Diagnostic & Imaging Centers
- Diagnostic Imaging
- Diagnostics Imaging
- Dosing & Administration
- Drug Allergy Alerting
- Drug Response Prediction
- Eprescribing
- Follow-Up & Long-Term Support
- Fraud Detection & Risk Management
- Generative Adversarial Networks (Gan)
- Graph Neural Networks (Gnn)
- Healthcare Assistance Robots
- Healthcare Workflow Management
- Home Healthcare Agencies & Assisted Living Facilities
- Hospitals & Clinics
- Immunotherapy
- Intraoperative Guidance & Robotics
- Ivd
- Long-Term Outcome Prediction
- Medication Management
- Medication Reminders
- Mental Health & Support Systems
- Motion Synchronization & Auto Contouring
- Other Administrative Functions
- Other Deep Learning Tools
- Other Diagnosis & Early Detection Functions
- Other Healthcare Providers
- Other Machine Learning Tools
- Other ML Tools
- Other Patient Engagement & Remote Monitoring Functions
- Other Pharmacological Therapy Functions
- Other Pharmacy Management Functions
- Other Radiation Therapy Functions
- Other Treatment Planning & Personalization Functions
- Patient Education & Empowerment
- Patient Eligibility & Authorization
- Patient Registration & Scheduling
- Pattern & Image Recognition
- Personalized Treatment Planning
- Pharmacies
- Pharmacological Therapy
- Pharmacy Audit & Analysis
- Physical Context
- Postoperative Analysis & Recovery
- Pre-Screening
- Precision Medicine & Genomic Analysis
- Predictive Models For Treatment Response
- Preoperative Imaging & 3D Modeling
- Private Payers
- Progress Monitoring & Feedback
- Public Payers
- Radiation Therapy
- Real-Time Adaptive Treatment Delivery
- Real-Time Patient Data Monitoring
- Recurrence Monitoring
- Recurrent Neural Networks (Rnn)
- Reinforcement Learning
- Relapse Prediction & Long-Term Management
- Response & Side-Effect Prediction
- Response Assessment & Quality Assurance
- Risk Assessment & Patient Stratification
- Sentiment Analysis
- Speech Recognition
- Supervised Learning
- Supply Chain & Inventory Management
- Surgical Therapy
- Symptom Management & Virtual Assistance
- Telehealth & Remote Patient Monitoring
- Text Analytics
- Treatment Recommendation Systems
- Unsupervised Learning
- User Context
- Virtual Counseling & Chatbots
- Workforce Management
By Technology
- Clinical Chemistry
- Immunoassays
- Molecular Diagnostics
By Application
- Biomarker Discovery & Analysis
- Clinical Applications
- Disease Interpretation & Report Analysis
- Image Analysis & Interpretation
- Image Captioning & Annotation
- Image Reconstruction
- Non-Clinical Applications
- Other Diagnostic Imaging Applications
- Other Ivd Applications
By Modality
- Computed Tomography (Ct)
- Magnetic Resonance Imaging (Mri)
- Nuclear Imaging (Pet & Spect)
- Other Diagnostic Imaging Modalities
- Ultrasound
- X-Ray Imaging
By Deployment Model
- Cloud-Based Models
- Hybrid Models
- On-Premise Models
By Tool
- Computer Vision
- Context-Aware Computing
- Generative AI
- Image Analysis
- Machine Learning (ML)
- Natural Language Processing (Nlp)
By End User
- Healthcare Payers
- Healthcare Providers
- Other End Users
- Patients
Target Audience
- Healthcare Technology Vendors : AI software and solution providers need Europe-specific market data to develop localized products, navigate regulatory requirements, and identify growth opportunities across diverse European healthcare systems and reimbursement models.
- Investment & Private Equity Firms : Investors require detailed European market analysis to identify high-growth segments, evaluate portfolio companies, and make informed capital allocation decisions in the rapidly expanding AI healthcare sector across Europe.
- Healthcare Providers & Hospital Networks : European hospitals and healthcare systems need market intelligence to benchmark AI adoption, evaluate vendor solutions, understand competitive positioning, and plan digital transformation investments aligned with market trends.
- Pharmaceutical & Biotech Companies : Drug developers and biotech firms require AI market insights to identify opportunities in drug discovery, clinical trials, and personalized medicine. European market data supports R&D investment decisions and partnership strategies.
- Government & Policy Makers : European health ministries and regulatory bodies need comprehensive market data to inform healthcare policy, funding decisions, and AI governance frameworks that balance innovation with patient safety and ethical considerations.
Key Companies in the Europe Artificial Intelligence (AI) in Healthcare Market
| Company | HQ | Ownership | Strongest segments |
|---|---|---|---|
| EPAM SYSTEMS, INC. | United States | ||
| SIEMENS AG | Germany | ||
| WNS GLOBAL SERVICES | India | ||
| L&T TECHNOLOGY SERVICES LIMITED | India | ||
| LARSEN & TOUBRO INFOTECH LIMITED | India | ||
| SOPRA STERIA | United States | ||
| CYIENT | India |
EPAM SYSTEMS, INC.
EPAM Systems, Inc. is a leading digital transformation and software engineering services company headquartered in the United States. The company provides consulting, software development, and IT services to clients across various industries globally.
SIEMENS AG
Siemens AG is a German multinational conglomerate providing automation, digitalization, and electrification solutions across industrial, infrastructure, and mobility sectors worldwide.
WNS GLOBAL SERVICES
WNS Global Services is an India-based business process management and IT services company offering customer engagement, finance and accounting, and technology solutions to global enterprises.
L&T TECHNOLOGY SERVICES LIMITED
L&T Technology Services Limited is an India-based engineering and technology services company providing design, engineering, and digital transformation solutions across multiple industries.
LARSEN & TOUBRO INFOTECH LIMITED
Larsen & Toubro Infotech Limited is an India-based IT services and consulting company offering digital transformation, cloud, and enterprise solutions to global clients.
SOPRA STERIA
Sopra Steria is a digital services and software company providing consulting, systems integration, and software development services, with operations in the United States and globally.
CYIENT
Cyient is an India-based engineering and technology services company specializing in digital, engineering, and cloud solutions for aerospace, defense, and industrial sectors.
Countries within Europe - compare and drill down
| Country | 2025 size (native) |
|---|---|
| Germany | USD 8953.6 Million |
| UK | USD 5839.6 Million |
| France | USD 6272.6 Million |
| Italy | USD 2742.8 Million |
| Spain | USD 2016.1 Million |
Country market size visualization
Reasons to Buy this Report
- Market Size & Growth Validation : Comprehensive data validating Europe's $21.63B market size in 2025 and $110.61B forecast for 2030. Detailed CAGR analysis at 38.6% enables accurate financial planning, investment decisions, and revenue projections specific to the European healthcare AI sector.
- Country-Level Intelligence : Granular market data for Germany ($8.95B), France ($6.27B), UK ($5.84B), Italy ($2.74B), and Spain ($2.02B). Country-specific insights enable targeted market entry strategies, competitive positioning, and localized business development across Europe's diverse healthcare systems.
- Regulatory & Compliance Insights : Deep understanding of Europe's unique regulatory landscape including EU AI Act, GDPR, and medical device directives. Critical for navigating compliance requirements, understanding market barriers, and identifying opportunities in Europe's structured healthcare environment.
- Competitive Landscape Analysis : Identify leading European AI healthcare providers, emerging startups, and innovation hubs. Strategic competitive intelligence enables market positioning, partnership identification, and understanding of regional competitive dynamics across major European markets.
- Investment & Partnership Opportunities : Discover high-growth segments, underserved markets, and strategic partnership opportunities across Europe. Data-driven insights support M&A decisions, venture capital allocation, and collaboration strategies with European healthcare institutions and technology providers.
Frequently asked questions
What is the projected size of Europe's AI in healthcare market by 2030?
Europe's AI in healthcare market is projected to reach $110.61 billion by 2030, growing from $21.63 billion in 2025 at a compound annual growth rate of 38.6%.
What factors are driving AI adoption in Europe's healthcare sector?
Europe's AI healthcare growth is driven by advanced healthcare infrastructure, stringent regulatory frameworks supporting responsible AI, substantial government R&D funding, high digital literacy, and collaborative research initiatives across member states.
How does Europe's approach to AI in healthcare differ from other regions?
Europe emphasizes ethical AI governance, data protection compliance (GDPR), interoperability standards, and responsible innovation, creating a regulatory environment that prioritizes patient safety and privacy alongside technological advancement.
Which AI applications are expected to grow fastest in Europe's healthcare market?
AI-powered diagnostic tools, predictive analytics for disease prevention, personalized medicine solutions, and clinical decision support systems are expected to see accelerated adoption across European healthcare institutions between 2025 and 2030.
What role does government funding play in Europe's AI healthcare market expansion?
Government funding across European nations supports AI research, infrastructure development, and clinical implementation programs, enabling healthcare providers to adopt AI solutions and fostering a competitive innovation ecosystem.
RESEARCH METHODOLOGY
The study involved significant efforts to estimate the current size of the artificial intelligence (AI) in healthcare market. Exhaustive secondary research was conducted to collect information on the artificial intelligence (AI) in healthcare market. The next step was to validate these findings, assumptions, and sizing estimates with industry experts across the value chain using primary research. Different approaches, such as top-down and bottom-up, were employed to estimate the total market size. After that, the market breakup and data triangulation procedures were used to estimate the market size of the segments and subsegments of the artificial intelligence (AI) in healthcare market.
Secondary Research
This research study involved the extensive use of secondary sources, directories, and databases such as Dun & Bradstreet, Bloomberg Businessweek, and Factiva; white papers, annual reports, and Companies House documents; investor presentations; and companies' SEC filings. The market for companies offering artificial intelligence (AI) in healthcare solutions is derived from secondary data available through paid and unpaid sources, analysis of the product portfolios of major companies in the ecosystem, and ratings of companies based on performance and quality. Various sources were consulted during the secondary research process to identify and collect information for this study. The secondary sources include annual reports, press releases, company investor presentations, white papers, journals, certified publications, articles by recognized authors, directories, and databases.
Various secondary sources were consulted during the secondary research process to identify and collect information relevant to the study. These sources included annual reports, press releases, investor presentations of artificial intelligence (AI) in healthcare vendors, forums, certified publications, and whitepapers. Secondary research was used to obtain critical information on the industry’s value chain, the pool of key players, market classification, and segmentation from market- and technology-oriented perspectives.
Primary Research
In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. Primary sources are mainly industry experts from the core and related industries, as well as preferred suppliers, manufacturers, distributors, technology developers, researchers, and organizations across all segments of this industry’s value chain. In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts (SMEs), C-level executives of key market players, and industry consultants, among other experts, to obtain and verify critical qualitative and quantitative information and to assess prospects.
Primary research was conducted to identify segmentation types, key players, and key market dynamics, including drivers, restraints, opportunities, challenges, and strategies adopted by key players.
After the complete market engineering (calculations for market statistics, market breakdown, market size estimates, market forecasting, and data triangulation), extensive primary research was conducted to gather information and verify and validate the critical numbers derived.
In the complete market engineering process, top-down and bottom-up approaches, along with several data triangulation methods, were extensively used to perform market estimation and forecasting across the overall market segments and subsegments listed in this report. Extensive qualitative and quantitative analyses were conducted on the complete market engineering process to identify key information/insights throughout the report.
Note 1: Other designations include sales, marketing, and product managers.
Note 2: Tiers are defined based on a company’s total revenue. As of 2025: Tier 1 = >USD 1 billion, Tier 2 = USD 500 million to USD 1 billion, and Tier 3 = <USD 500 million.
To know about the assumptions considered for the study, download the pdf brochure
Market Size Estimation
The market size estimates and forecasts provided in this study are derived through a mix of the bottom-up approach (revenue share analysis of leading players) and top-down approach (assessment of utilization/adoption/penetration trends, by offering, function, application, deployment, tool, end user, and region).
Data Triangulation
After arriving at the overall market size—using the market size estimation processes—the market was split into several segments and subsegments. To complete the overall market engineering process and obtain the exact statistics for each market segment and subsegment, data triangulation and market breakdown procedures were employed wherever applicable. The data was triangulated by examining various factors and trends on both the demand and supply sides of the artificial intelligence (AI) in healthcare market.
Market Definition
The artificial intelligence (AI) in healthcare market encompasses the application of AI technologies, such as machine learning, natural language processing, computer vision, and robotics, to improve healthcare delivery, enhance operational efficiency, and provide personalized care. These solutions address a wide range of use cases, including diagnostic imaging, predictive analytics, drug discovery, patient engagement, remote monitoring, and administrative workflows, enabling healthcare providers, payers, and pharmaceutical companies to drive innovation and improve outcomes.
Key Stakeholders
- Artificial intelligence (AI) in healthcare software vendors
- Artificial intelligence (AI) in healthcare service providers
- Independent software vendors (ISVs)
- Platform providers
- Technology providers
- System integrators
- Cloud service providers
- Healthcare IT service providers
- Hospitals and surgical centers
- Diagnostic imaging centers
- Academic institutes and research laboratories
- Forums, alliances, and associations
- Government organizations
- Institutional investors and investment banks
- Investors/Shareholders
- Venture capitalists
- Research and consulting firms
Report Objectives
- To define, describe, and forecast the global artificial intelligence (AI) in healthcare market based on offering, function, application, deployment, tool, end user, and region
- To provide detailed information regarding the factors influencing the growth of the market (such as the drivers, restraints, opportunities, and challenges)
- To strategically analyze micromarkets with respect to individual growth trends, prospects, and contributions to the overall artificial intelligence (AI) in healthcare market
- To analyze market opportunities for stakeholders and provide details of the competitive landscape for market leaders
- To forecast the size of the artificial intelligence (AI) in healthcare market in five main regions (along with their respective key countries): North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa
- To profile key players and comprehensively analyze their product portfolios, market positions, and core competencies in the market
- To track and analyze competitive developments such as product & service launches; expansions; partnerships, agreements, and collaborations; and acquisitions in the artificial intelligence (AI) in healthcare market
- To benchmark players within the artificial intelligence (AI) in healthcare market using the Company Evaluation Matrix framework, which analyzes market players on various parameters within the broad categories of business strategy, market share, and product offering.
Available customizations:
With the given market data, MarketsandMarkets offers customizations as per your company’s specific needs. The following customization options are available for the report:
Company Information
- Detailed analysis and profiling of additional market players (up to 5)
Geographic Analysis
- Further breakdown of the Rest of Europe artificial intelligence (AI) in healthcare market into Denmark, Norway, and others
- Further breakdown of the Rest of Asia Pacific artificial intelligence (AI) in healthcare market into Vietnam, New Zealand, Australia, South Korea, and others
Get the Full Artificial Intelligence (AI) in Healthcare Market Report
Full forecast, segment splits, and company analysis for all Artificial Intelligence (AI) in Healthcare Market.
- US Artificial Intelligence (AI) in Healthcare Market
- Canada Artificial Intelligence (AI) in Healthcare Market
- Germany Artificial Intelligence (AI) in Healthcare Market
- UK Artificial Intelligence (AI) in Healthcare Market
- France Artificial Intelligence (AI) in Healthcare Market
- Italy Artificial Intelligence (AI) in Healthcare Market
- Spain Artificial Intelligence (AI) in Healthcare Market
- China Artificial Intelligence (AI) in Healthcare Market
- Japan Artificial Intelligence (AI) in Healthcare Market
- India Artificial Intelligence (AI) in Healthcare Market
- Brazil Artificial Intelligence (AI) in Healthcare Market
- Mexico Artificial Intelligence (AI) in Healthcare Market
Need a Tailored Report?
Customize this report to your needs
Get 10% FREE Customization
Customize This Report